Sai Life Sciences Limited (BOM:544306)
India · Delayed Price · Currency is INR 1,144.20
-16.05 (-1.38%)
At close: Jun 1, 2026
Sai Life Sciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 3,489 | 1,701 | 828.09 | 99.89 | 62.26 |
Depreciation & Amortization | 1,669 | 1,290 | 1,107 | 948.59 | 869.2 |
Other Amortization | - | 96.19 | 87.67 | 45.73 | 32.41 |
Loss (Gain) From Sale of Assets | 9.63 | 18.11 | -0.1 | 5.67 | -113.15 |
Asset Writedown & Restructuring Costs | 0.49 | 17.2 | 61.86 | - | - |
Loss (Gain) From Sale of Investments | -4.92 | - | - | - | - |
Stock-Based Compensation | 21.04 | 24.78 | 22.53 | 8.14 | 22.41 |
Provision & Write-off of Bad Debts | -249.35 | 309.09 | 77.94 | 79.48 | 61.16 |
Other Operating Activities | 894.74 | 995.14 | 828.61 | 657.27 | 359.87 |
Change in Accounts Receivable | -154.17 | -999.65 | 288.14 | -450.79 | -432.45 |
Change in Inventory | -321.03 | -314.22 | 520.87 | -126.17 | -505.64 |
Change in Accounts Payable | 327.09 | 1,059 | -700.51 | 123.85 | 642.96 |
Change in Other Net Operating Assets | -589.84 | -1,056 | -490.92 | 802.37 | 49.63 |
Operating Cash Flow | 5,091 | 3,140 | 2,631 | 2,194 | 1,049 |
Operating Cash Flow Growth | 62.12% | 19.37% | 19.91% | 109.22% | - |
Capital Expenditures | -5,930 | -3,693 | -1,817 | -1,131 | -2,069 |
Sale of Property, Plant & Equipment | 5.18 | 4.77 | 8.53 | 419.07 | 985.42 |
Investment in Securities | -1,176 | -20.75 | 950 | -368.52 | 5 |
Other Investing Activities | 3,146 | -1,658 | -1,065 | 62.39 | 41.58 |
Investing Cash Flow | -3,954 | -5,367 | -1,924 | -1,018 | -1,037 |
Short-Term Debt Issued | - | - | 248.93 | - | 739.39 |
Long-Term Debt Issued | 255.04 | 534.08 | 750 | 300 | 1,001 |
Total Debt Issued | 255.04 | 534.08 | 998.93 | 300 | 1,741 |
Short-Term Debt Repaid | -588.9 | -2,340 | - | -664.36 | - |
Long-Term Debt Repaid | -615.52 | -4,409 | -1,108 | -877.99 | -552.2 |
Total Debt Repaid | -1,204 | -6,749 | -1,108 | -1,542 | -552.2 |
Net Debt Issued (Repaid) | -949.38 | -6,215 | -109.4 | -1,242 | 1,189 |
Issuance of Common Stock | 250.94 | 10,116 | 9.67 | 20.91 | 31.25 |
Other Financing Activities | -538.36 | -887.31 | -853.26 | -785.04 | -500.69 |
Financing Cash Flow | -1,237 | 3,014 | -952.99 | -2,006 | 719.23 |
Foreign Exchange Rate Adjustments | 8.2 | 2.78 | 10.33 | 27.8 | 20.75 |
Net Cash Flow | -91.38 | 790.83 | -235.6 | -802.46 | 751.5 |
Free Cash Flow | -838.28 | -552.35 | 813.97 | 1,063 | -1,020 |
Free Cash Flow Growth | - | - | -23.45% | - | - |
Free Cash Flow Margin | -3.82% | -3.26% | 5.56% | 8.74% | -11.73% |
Free Cash Flow Per Share | -3.95 | -2.79 | 4.45 | 5.83 | -5.62 |
Cash Interest Paid | 339.87 | 774.11 | 853.26 | 785.04 | 500.69 |
Cash Income Tax Paid | 389.27 | 216.31 | 138.73 | 40.8 | 81.23 |
Levered Free Cash Flow | -1,302 | -1,989 | -254.98 | -19.44 | -2,056 |
Unlevered Free Cash Flow | -1,057 | -1,513 | 281.96 | 462.16 | -1,746 |
Change in Working Capital | -737.95 | -1,311 | -382.42 | 349.26 | -245.5 |